Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-04-15 @ 5:05 PM
Study NCT ID:
NCT03020095
Status:
COMPLETED
Last Update Posted:
2020-10-22
First Post:
2017-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan
Sponsor:
Ascletis Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-05
First Submit QC Date:
None
Study First Post Date:
2017-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-18
Results First Submit QC Date:
None
Results First Post Date:
2020-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-20
Last Update Post Date:
2020-10-22
Last Update Post Date Type:
ACTUAL